Acknowledgement
이 연구는 2019년도 정부의 재원으로 한국연구재단의 지원을 받아 수행된 기초연구사업임 (No. NRF2019R1A2C1002443).
References
- Kim JH. Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis. 2004;14(1):12-23.
- Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-60. https://doi.org/10.1016/S0140-6736(03)12193-9
- Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-9. https://doi.org/10.1016/j.jaci.2012.12.672
- Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-22. https://doi.org/10.1016/S0140-6736(15)00149-X
- Zheng T, Yu JH, Oh MH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3(2):1052242
- Jee HM, Kim KW, Kim CS, Sohn MH, Shin DC, Kim KE. Prevalence of asthma, rhinitis and eczema in Korean children using the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires. Pediatr Allergy Respir Dis. 2009;19(2):165-72.
- Im GM, Joeng HW, Kim HS, Jeong WY. Oriental medical approach on the allergic disease. Korea J Oriental Physiology & Pathology. 2002;16(5):831-9.
- Ahn KM, Kim JH, Kwon HJ, Chae YM, Hahm MI, Lee KJ, Park YM, Lee SY, Han MY, Kim WK. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011;54(7):769-78. https://doi.org/10.5124/jkma.2011.54.7.769
- Kim MJ, Lee SY. A literature study of atopic dermatitis for children. J Pediatr Korean Med. 2000;14(2):167-82.
- Heo J. Donguibogam. 4th ed. Seoul: Namsandang. 1994:145.
- Lee DS, Choi HG, Kim KS, Kim DC, Min HK, Li B, Park JH, Oh HC, Kim YC. The comparison between Sabaek-san water and 30% EtOH extracts for anti-inflammatory effects. Yahak Hoeji. 2012;56(4): 240-7.
- Ahn SH, Jeong AR, Kim KB. Th2 differentiation control through formation of skin fat barrier of Sabaek-san extract. J Pediatr Korean Med. 2022;36(1):57-64.
- Lee HJ. Effects of Sabaek-san on the metrix metalloproteinase-9 in the bronchial asthma mouse model. JPPKM. 2004;18(6):1694-8.
- Baron ED, Barzilai D, Johnston G, Kawashima M, Takigawa M, Nakagawa H, Graham-Browh R. Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol. 2002;147:710-5. https://doi.org/10.1046/j.1365-2133.2002.04895.x
- Kang MY, Jang GT, Kim JH. A study on fetal toxicosis removal therapy. J Pediatr Korean Med. 2003;17(1):29-51.
- Lee HJ. Effects of Sabaek-san on the metrix metalloproteinase-9 in the bronchial asthma mouse model. JPPKM. 2004;18(6):1694-8.
- Park SH, Park HJ. Root bark extract of Morus alba L. suppressed the migration and invasion of HCT116 human colorectal carcinoma cells. JPPKM. 2021;35(5):177-84. https://doi.org/10.15188/kjopp.2021.10.35.5.177
- Korean Medical Pharmacology Text Publication Committee. Korean medical pharmacology. 3rd ed. Seoul: Shinil Books. 2010:116-249.
- Salzet M. Invertebrate molecular neuroimmune processes. Brain Res Rev, 2000;34(1):69-79. https://doi.org/10.1016/S0165-0173(00)00041-2
- Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev. 2011;63(3):461-70. https://doi.org/10.1124/pr.110.003491
- Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462. https://doi.org/10.1124/pr.58.3.2
- Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol. 2009;18(8):669-79. https://doi.org/10.1111/j.1600-0625.2009.00923.x
- Luger TA. Neuromediators--a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93. https://doi.org/10.1016/S0923-1811(02)00103-2
- Maccarrone M, Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278(36):33896-903. https://doi.org/10.1074/jbc.M303994200
- Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 2007;316(5830):1494-7. https://doi.org/10.1126/science.1142265
- Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003;111(1):43-50. https://doi.org/10.1172/JCI200316116
- Piazza PV, Lafontan M, Girard J. Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system. Diabetes Metab. 2007;33(2):97-107. https://doi.org/10.1016/j.diabet.2007.02.002
- Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 2005;168:509-54. https://doi.org/10.1007/3-540-26573-2_17
- Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152(5):624-32. https://doi.org/10.1038/sj.bjp.0707433
- Toth KF, Adam D, Biro T, Olah A. Cannabinoid signaling in the skin: therapeutic potential of the "c(ut)annabinoid" system. Molecules. 2019;24(5):918. https://doi.org/10.3390/molecules24050918
- Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med. 2002;30(1) Suppl:74-9.
- Chung, HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30. https://doi.org/10.1016/j.arr.2008.07.002
- Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20. https://doi.org/10.1016/S0092-8674(00)81318-5
- Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sciences. 2004;75(6):639-53. https://doi.org/10.1016/j.lfs.2003.10.042
- Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344(1):30-7. https://doi.org/10.1056/NEJM200101043440106